Breaking News

SGS To Open New GMP/GLP Lab in CA

By Kristin Brooks | January 15, 2014

Will provide microbiological testing and bioanalytical services

SGS is investing in a fifth North American Life Science Services lab in Carson, CA. The 8,000-sq.-ft. Life Science Services GMP/GLP lab will provide microbiological testing and bioanalytical services. The new facility will include 6,000 sq. ft. of dedicated lab space and 2,000 sq. ft. of office space. The facility is projected to open 3Q14 and will initially employ seven scientific staff, with room to expand.
“We are very pleased to undertake this project because it allows SGS to establish a West Coast, Life Science Services presence to address the California pharmaceutical and biotechnology market,” said Jeff McDonald, chief operating officer, SGS North America.
“This development permits SGS to leverage the bioanalytical testing expertise from the laboratory in Poitiers, France, where SGS has more than 700 validated bioanalytical assays to date,” added Anne Hays, executive vice president, Life Science Services.
SGS has 20 labs offering contract analytical and bioanalytical services and is present in North America, Europe, and Asia. SGS also provides clinical trial management (Phase I to IV) and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance and regulatory consultancy.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important